Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-11 · accession 0001209191-22-018845 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-15 | 2022-03-12+ | IART | Coleman Glenn | EVP, COO | F - Tax | $65.11 | -17.0K | 58.0K | -23% | -$1.11M |
| D | 2022-03-15 | 2022-03-11 | IART | Coleman Glenn | EVP, COO | A - Grant | $0.00 | +7,119 | 64.6K | +12% | $0 |
| D | 2022-03-15 | 2022-03-11 | IART | Coleman Glenn | EVP, COO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-13 | F | D | 1,424 | $65.11 | 55.80 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-13 | F | D | 775 | $65.11 | 57,220 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-11 | A | A | 7,119 | $0.00 | 64,578 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-12 | F | D | 3,706 | $65.11 | 59,765 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-12 | F | D | 1,107 | $65.11 | 63,471 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-13 | F | D | 5,338 | $65.11 | 47,556 | D | — | — | |
| 7 | Common | Common Stock | 2022-03-13 | F | D | 2,902 | $65.11 | 52,894 | D | — | — | |
| 8 | Common | Common Stock | 2022-03-12 | F | D | 1,770 | $65.11 | 57,995 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-11 | A | A | 20,023 | $0.00 | 20,023 | D | $65.11 · — to 2030-03-11 | 20,023 Common Stock | (F1) 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. |